Impact of Troxerutin Combined with Dual Antiplatelet Regimen on Neurological Function and Prognosis of Patients with A-cute Cerebral Infarction
Objective To explore the clinical effect of troxerutin combined with dual antiplatelet regimen in the treatment of patients with acute cerebral infarction(ACI).Methods 70 ACI patients admitted to our hospital from August 2020 to February 2023 were selected and randomly divided into two groups,with 35 cases in each group.On the basis of conventional therapy,the control group was treated with dual antiplatelet drugs(aspirin+clopidogrel),and the treatment group was treated with troxerutin on the basis of the control group.The clinical efficacy,neurological function and prognosis quality were compared between the two groups.Results The total effective rate of the treatment group was 94.29%,higher than 77.14%of the control group(P<0.05).After treatment,the NIHSS score of the treatment group was lower than that of the control group,and the BI score was higher than that of the control group(P<0.05).Conclusions Troxerutin combined with dual antiplatelet regimen in the treatment of ACI patients has significant effect,which can effectively promote the recovery of neurological function and improve the prognosis of patients.